Parallel study as pilot for long half life drug [Design Issues]

posted by jag009  – NJ, 2012-05-07 17:13 (5148 d 12:07 ago) – Posting: # 8524
Views: 6,600

Hi everyone,

I am working on a drug with a half life of 100-120 hrs :angry: and so far I haven't been able to get any information about its intrasubject CV. Due to timing issues, I am considering running a pilot parallel study to compare a prototype generic against the innovator.

Question. If I proceed with this, does that mean I will have to conduct my pivotal studies as parallel studies since the CV I get from the pilot is the total CV?

Thanks

John

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
170 visitors (0 registered, 170 guests [including 35 identified bots]).
Forum time: 05:21 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5